At a glance
- Originator Nonindustrial source
- Class Cytostatic antibiotics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 19 Jun 2001 No-Development-Reported for Cancer in USA (Unknown route)
- 19 Jun 2001 Preclinical development for Cancer in Spain (Unknown route)
- 13 Jul 1998 Preclinical development for Cancer in USA (Unknown route)